The value of CDC42 effector protein 2 as a novel prognostic biomarker in liver hepatocellular carcinoma: a comprehensive data analysis
Objectives The prognostic significance of CDC42 effector protein 2 (CDC42EP2) and its association with tumor-infiltrating immune cells (TIICs) have not been explored in liver hepatocellular carcinoma (LIHC). This study aims to assess the potential prognostic value of CDC42EP2 by conducting a compreh...
Main Authors: | Hye-Ran Kim, Choong Won Seo, Jongwan Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
Korea Disease Control and Prevention Agency
2023-12-01
|
Series: | Osong Public Health and Research Perspectives |
Subjects: | |
Online Access: | http://ophrp.org/upload/pdf/j-phrp-2023-0229.pdf |
Similar Items
-
Novel Gene Signatures as Prognostic Biomarkers for Predicting the Recurrence of Hepatocellular Carcinoma
by: Ju A Son, et al.
Published: (2022-02-01) -
Yes-associated protein 1 as a prognostic biomarker and its correlation with telomerase in various cancers
by: Hye-Ran Kim, et al.
Published: (2021-10-01) -
Comprehensive analysis of ASB3 as a prognostic biomarker in hepatocellular carcinoma
by: Zhongqiang Qin, et al.
Published: (2024-01-01) -
Sarcopenia and blood myokine levels as prognostic biomarkers in patients with liver cirrhosis or hepatocellular carcinoma
by: Sooyeon Oh, et al.
Published: (2020-10-01) -
Zinc Finger E-Box Binding Homeobox 2 as a Prognostic Biomarker in Various Cancers and Its Correlation with Infiltrating Immune Cells in Ovarian Cancer
by: Hye-Ran Kim, et al.
Published: (2022-03-01)